These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38954728)

  • 1. Detection of disease-specific signatures in B cell repertoires of lymphomas using machine learning.
    Schmidt-Barbo P; Kalweit G; Naouar M; Paschold L; Willscher E; Schultheiß C; Märkl B; Dirnhofer S; Tzankov A; Binder M; Kalweit M
    PLoS Comput Biol; 2024 Jul; 20(7):e1011570. PubMed ID: 38954728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populations.
    Bashford-Rogers RJ; Palser AL; Huntly BJ; Rance R; Vassiliou GS; Follows GA; Kellam P
    Genome Res; 2013 Nov; 23(11):1874-84. PubMed ID: 23742949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Influence of B-Cell Receptor Rearrangement and Somatic Hypermutation on B-Cell Class-Switch Fate in Health and in Chronic Lymphocytic Leukemia.
    Petrova VN; Muir L; McKay PF; Vassiliou GS; Smith KGC; Lyons PA; Russell CA; Anderson CA; Kellam P; Bashford-Rogers RJM
    Front Immunol; 2018; 9():1784. PubMed ID: 30147686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
    Kubuschok B; Trepel M
    Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL.
    Perfecto-Avalos Y; Garcia-Gonzalez A; Hernandez-Reynoso A; Sánchez-Ante G; Ortiz-Hidalgo C; Scott SP; Fuentes-Aguilar RQ; Diaz-Dominguez R; León-Martínez G; Velasco-Vales V; Cárdenas-Escudero MA; Hernández-Hernández JA; Santos A; Borbolla-Escoboza JR; Villela L
    J Transl Med; 2019 Jun; 17(1):198. PubMed ID: 31185999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Analysis of Naïve B-Cell Receptor Repertoires Stratifies Celiac Disease Patients and Controls.
    Shemesh O; Polak P; Lundin KEA; Sollid LM; Yaari G
    Front Immunol; 2021; 12():627813. PubMed ID: 33790900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome).
    Nakamura N; Kuze T; Hashimoto Y; Hoshi S; Tominaga K; Sasaki Y; Shirakawa A; Sato M; Maeda K; Abe M
    Pathol Int; 2000 Aug; 50(8):636-43. PubMed ID: 10972862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capturing the differences between humoral immunity in the normal and tumor environments from repertoire-seq of B-cell receptors using supervised machine learning.
    Konishi H; Komura D; Katoh H; Atsumi S; Koda H; Yamamoto A; Seto Y; Fukayama M; Yamaguchi R; Imoto S; Ishikawa S
    BMC Bioinformatics; 2019 May; 20(1):267. PubMed ID: 31138102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma.
    Zhang W; Yang L; Guan YQ; Shen KF; Zhang ML; Cai HD; Wang JC; Wang Y; Huang L; Cao Y; Wang N; Tan XH; Young KH; Xiao M; Zhou JF
    BMC Cancer; 2020 Jul; 20(1):714. PubMed ID: 32736575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications.
    Hengeveld PJ; Levin MD; Kolijn PM; Langerak AW
    Exp Hematol; 2021 Jan; 93():14-24. PubMed ID: 32976948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
    Dahl M; Kristensen LS; Grønbæk K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in extracutaneous lymphomas.
    Chott A; Raderer M
    Semin Cutan Med Surg; 2000 Jun; 19(2):149-56. PubMed ID: 10892718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma.
    Jiang Y; Nie K; Redmond D; Melnick AM; Tam W; Elemento O
    J Vis Exp; 2015 Dec; (106):e53215. PubMed ID: 26780364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
    Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.